Travere Therapeutics, Inc. (TVTX) › EPS (Basic)Travere Therapeutics, Inc. (TVTX) — EPS (Basic)Annual figures by period end, from SEC filings.2013-12-31: $-2.442014-12-31: $-4.432015-12-31: $3.492016-12-31: $-1.292017-12-31: $-1.542018-12-31: $-2.542019-12-31: $-3.462020-12-31: $-3.562021-12-31: $-3.012022-12-31: $-4.372023-12-31: $-1.502024-12-31: $-4.082025-12-31: $-0.29$-0.292013-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-0.29—2026-02-19From 2025-01-012024-12-31$-4.08—2026-02-19From 2024-01-012023-12-31$-1.50—2026-02-19From 2023-01-012022-12-31$-4.37—2025-02-21From 2022-01-012021-12-31$-3.01—2024-02-20From 2021-01-012020-12-31$-3.56—2023-02-23From 2020-01-012019-12-31$-3.46—2022-02-24From 2019-01-012018-12-31$-2.54—2019-02-26From 2018-01-012017-12-31$-1.54—2019-02-26From 2017-01-012016-12-31$-1.29-137.0%2019-02-26From 2016-01-012015-12-31$3.49—2018-07-06From 2015-01-012014-12-31$-4.43—2017-03-01From 2014-01-012013-12-31$-2.44—2016-02-26From 2013-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares